📗 Cite This Artifact
SfN Neuroscience 2026 — Neurodegeneration Research Highlights
SFN 2026
Overview
The Society for Neuroscience (SfN) Annual Meeting is the world's largest gathering of neuroscientists, bringing together researchers from academia, industry, and clinical settings to present cutting-edge research on brain function and neurological disorders. SfN Neuroscience 2026 will be held November 14-18, 2026, at the Walter E. Washington Convention Center in Washington, D.C. [1](https://www.sfn.org/meetings/neuroscience-2026)
This page documents the neurodegeneration-related content from SfN 2026, including poster presentations, symposia, and late-breaking science relevant to Alzheimer's disease (AD), Parkinson's disease (PD), and related disorders.
Meeting Information
| Item | Details |
|------|---------|
| Dates | November 14-18, 2026 |
| Location | Walter E. Washington Convention Center, Washington, D.C. |
| Abstract Submission | May 27 – June 10, 2026 (closed) |
| Registration Opens | July 15, 2026 (members); July 21, 2026 (non-members) |
| Neuroscience Networking Events | Submission deadline: October 22, 2026 |
Neurodegeneration Themes and Topics
SfN 2026 features extensive neurodegeneration-related content organized under Theme C: Neural Aging and Degeneration, and Theme D: Neuroimmunity, Neurovasculature, and Neural Injury.
Theme C: Neural Aging and Degeneration
C.01 — Brain Wellness and Aging
- C.01.a-g: Molecular and cellular changes, metabolism/oxidative stress, pharmacological interventions, systemic factors, biomarkers, natural brain aging mechanisms, and cognitive disorders
SFN 2026
Overview
The Society for Neuroscience (SfN) Annual Meeting is the world's largest gathering of neuroscientists, bringing together researchers from academia, industry, and clinical settings to present cutting-edge research on brain function and neurological disorders. SfN Neuroscience 2026 will be held November 14-18, 2026, at the Walter E. Washington Convention Center in Washington, D.C. [1](https://www.sfn.org/meetings/neuroscience-2026)
This page documents the neurodegeneration-related content from SfN 2026, including poster presentations, symposia, and late-breaking science relevant to Alzheimer's disease (AD), Parkinson's disease (PD), and related disorders.
Meeting Information
| Item | Details |
|------|---------|
| Dates | November 14-18, 2026 |
| Location | Walter E. Washington Convention Center, Washington, D.C. |
| Abstract Submission | May 27 – June 10, 2026 (closed) |
| Registration Opens | July 15, 2026 (members); July 21, 2026 (non-members) |
| Neuroscience Networking Events | Submission deadline: October 22, 2026 |
Neurodegeneration Themes and Topics
SfN 2026 features extensive neurodegeneration-related content organized under Theme C: Neural Aging and Degeneration, and Theme D: Neuroimmunity, Neurovasculature, and Neural Injury.
Theme C: Neural Aging and Degeneration
C.01 — Brain Wellness and Aging
- C.01.a-g: Molecular and cellular changes, metabolism/oxidative stress, pharmacological interventions, systemic factors, biomarkers, natural brain aging mechanisms, and cognitive disorders
C.02 — Alzheimer's Disease and Other Dementias
This is the most comprehensive section, covering:
- Genetics and Genomics: C.02.a-b — Genetic factors and transcriptomics
- Omics Approaches: C.02.c — Multi-omics, proteomics, lipidomics, metabolomics
- Neuroinflammation: C.02.d-f — In vitro/in vivo models, glial cell involvement
- Vascular and Metabolic: C.02.g — Blood flow and metabolism
- Neural Circuitry: C.02.h-i — Synaptic dysfunction and circuit analysis
- Biomarkers and Imaging: C.02.j-s — Imaging approaches and fluid biomarkers
- Therapeutic Strategies: C.02.n-p — Amyloidosis models, tau therapeutics, other approaches
- Proteinopathies: C.02.q — Other dementias and proteinopathies
C.03 — Parkinson's Disease
Comprehensive PD coverage including:
- Molecular Mechanisms: C.03.a-b — Alpha-synuclein and LRRK2
- Cellular and Circuit Mechanisms: C.03.c-d
- Animal Models: C.03.e
- Neuroprotection: C.03.f
- Therapeutic Strategies: C.03.g-j — Cellular models, preclinical/clinical trials
- Human Studies: C.03.k-l — Genetics, diagnostics, and neuroinflammation
C.04 — Movement Disorders
- C.04.a — Huntington's disease
- C.04.b-c — Ataxias, dystonia, and tremors
C.05 — Tauopathies and Synucleinopathies
- C.05.a-b — Cellular/molecular mechanisms and animal models
C.06 — Neuromuscular Diseases
- C.06.a-e — ALS and motor neuron diseases, including genetics, in vitro studies, animal models, and therapeutics
Theme D: Neuroimmunity, Neurovasculature, and Neural Injury
D.01 — Neurotoxicity, Inflammation, and Neuroprotection
- D.01.a-g: Cellular stress, neuroprotective mechanisms, microglia, neuroinflammation models, HIV/infectious agents, and neuroinvasive viruses
Additional sections cover ischemia (D.02), stroke (D.03), brain injury (D.04), spinal cord/peripheral nerve injury (D.05), and multiple sclerosis (D.06).
Poster Session Framework
The following categories will be used to organize poster highlights from SfN 2026. Abstract submissions closed June 10, 2026, and the detailed program will be available closer to the meeting date.
Alzheimer's Disease Posters
To be populated with poster details after program release
Parkinson's Disease Posters
To be populated with poster details after program release
ALS and Motor Neuron Disease Posters
To be populated with poster details after program release
Neuroinflammation and Glia Posters
To be populated with poster details after program release
Protein Aggregation and Propagation Posters
To be populated with poster details after program release
Therapeutic Strategies Posters
To be populated with poster details after program release
Session Types
Presidential Special Lectures
The Presidential Special Lectures feature leading neuroscientists presenting groundbreaking research across various topics.
Dialogues Between Neuroscience and Society Lecture
This lecture series explores the intersection of neuroscience with societal issues, bringing public awareness to brain research.
Neuroscience Networking Events
Networking events provide opportunities for collaboration and discussion. Submission deadline: October 22, 2026.
Satellite Events
On-site satellite events offer specialized workshops and demonstrations.
Related Pages
- [SfN 2026: Neurodegeneration Sessions](/events/sfn-2026/neurodegeneration) — AD, PD, ALS tracks
- [SfN 2026: Neural Circuit Research](/events/sfn-2026/neural-circuits) — Synaptic dysfunction
- [SfN 2026: Glial Biology](/events/sfn-2026/glial-biology) — Neuroinflammation and glia
- [SfN 2026: ALS and Motor Neuron Disease](/events/sfn-2026/als-motor-neuron-disease) — ALS, SMA, SBMA
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Amyotrophic Lateral Sclerosis (ALS)](/diseases/amyotrophic-lateral-sclerosis)
- [Alpha-Synuclein Aggregation Pathway](/mechanisms/alpha-synuclein-aggregation-pathway)
- [Tau Pathology Pathway](/mechanisms/tau-pathology-pathway)
- [Neuroinflammation in AD/PD/ALS](/mechanisms/neuroinflammation-ad-pd-als)
- [LRRK2 Signaling Pathway](/mechanisms/lrrk2-signaling-pathway)
See Also
- [Mechanisms](/mechanisms)
External Links
- [PubMed](https://pubmed.ncbi.nlm.nih.gov/)
- [ClinicalTrials.gov](https://clinicaltrials.gov/)
References
▸Metadataorigin_type: v1_polymorphic_backfill
| slug | events-sfn-2026 |
| kg_node_id | None |
| entity_type | event |
| origin_type | v1_polymorphic_backfill |
| source_table | wiki_pages |
| wiki_page_id | wp-b5b3962d990a |
| __merged_from | {'merged_at': '2026-05-13', 'unprefixed_id': 'events-sfn-2026'} |
| _schema_version | 1 |
No provenance edges found
Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.
<iframe src="http://scidex.ai/artifact/wiki-events-sfn-2026?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>
[SfN Neuroscience 2026 — Neurodegeneration Research Highlights](http://scidex.ai/artifact/wiki-events-sfn-2026)
http://scidex.ai/artifact/wiki-events-sfn-2026